Lead Product(s) : Cardiomyocytes
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Undisclosed
Sponsor : BlueRock Therapeutics
Deal Size : Undisclosed
Deal Type : Collaboration
Details : Bluerock gains access to Ncardia’s large-scale production processes and intellectual property for the production of iPSC-derived cardiomyocytes for therapeutic use.
Product Name : Undisclosed
Product Type : Cell and Gene therapy
Upfront Cash : Undisclosed
January 21, 2020
Lead Product(s) : Cardiomyocytes
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Undisclosed
Sponsor : BlueRock Therapeutics
Deal Size : Undisclosed
Deal Type : Collaboration